HealthCare Biotech Investors

Kanglu Bio is positioned to provide clinical diagnosis and guidance for clinical drug molecular diagnostic products and clinical molecular diagnostics overall service providers for clinical hospitals and third-party clinical independent testing institutions. The products and services are mainly used in cardiovascular and cerebrovascular diseases. Major diseases such as tumors and cancer.

Headquarters: Wuhan, Hubei, China
Founded Date: 2013
Employee Number: 51-100
Industry: Other
Investor Type: Healthcare Company